Companies at CHEMPARK

CHEMPARK Leverkusen

More than 70 companies specializing in production, research and services help generate synergies at CHEMPARK.

Below you will find the company profiles of our CHEMPARK partners:

AIR LIQUIDE Deutschland GmbH
Altrad Germany GmbH
ALTRAD Kiel Industrial Services GmbH
ARLANXEO Deutschland GmbH
Asahi Kasei Spandex Europe GmbH
Atos Information Technology GmbH
Ausbildungsinitiative Rheinland GmbH
Baumann Logistik GmbH & Co. KG
Bayer AG
Bayer Gastronomie GmbH
Bayer Real Estate GmbH
Bayer Vital GmbH
Bertschi AG
Bilfinger Engineering & Maintenance GmbH
BUCHEN UmweltService GmbH
Chemion Logistik GmbH
Computacenter AG & Co. oHG
consilab - Gesellschaft für Anlagensicherheit mbH
Covestro AG
Currenta GmbH & Co. OHG
Ebert Hera Esser Group
Echoes Industrieservice GmbH
Evonik Operations GmbH
GMA-Werkstoffprüfung GmbH
HDL Glas- und Kunststoffanlagenbau GmbH
Heraeus Deutschland GmbH & Co. KG
Horst Götz GmbH & Co. KG Industriereinigung
HOYER GmbH Internationale Fachspedition
Impuls Fitness- und Gesundheitssport GmbH
Indulor Leverkusen GmbH & Co. KG
INEOS Styrolution Köln GmbH
Ingenieurbüro Grobecker GmbH
INVITE GmbH
KARL SCHMIDT SPEDITION GmbH & Co. KG
Kemira Germany GmbH TM Dormagen
KRONOS TITAN GmbH
LANXESS AG
LEVACO Chemicals GmbH
Linde Aktiengesellschaft, Linde Gas division
Momentive Performance Materials
Nippon Gases Deutschland GmbH
NKT GmbH & Co. KG
Nouryon Chemicals GmbH
Pallas Versicherung AG
Polymaterials AG
Powder Tec GmbH
pronova BKK
RWE Generation SE
Saltigo GmbH
SIDRA Wasserchemie GmbH
TALKE-Emmerich GmbH & Co. KG
Tectrion GmbH
TERRITORY Content to Results GmbH
TFL Ledertechnik GmbH
TH Köln - University of Applied Sciences
TÜV SÜD Chemie Service GmbH
UL Solutions
VENATOR Uerdingen GmbH
Weber Industrieller Rohrleitungsbau & Anlagenbau GmbH & Co. KG
Würth
WuXi Biologics Germany GmbH
YNCORIS GmbH & Co. KG

WuXi Biologics Germany GmbH

WuXi Biologics (stock code: 2269.HK), a Hong Kong-listed company, is a leading global open-access biologics technology platform offering end-to-end solutions to empower organizations to discover, develop, and manufacture biologics from concept to commercial manufacturing. The company’s history and achievements demonstrate its commitment to providing a truly one-stop service offering and strong value proposition to its global clients.

The company is currently conducting (as of March 22, 2021) a total of 361 integrated projects: 190 in pre-clinical development; 137 in early-phase (phase I and II) clinical development; 32 in late-phase (phase III) development; and 2 in commercial manufacturing. With a total estimated capacity at around 430,000 liters for biopharmaceutical production planned by 2024 in China, Ireland, the U.S., Germany, and Singapore, WuXi Biologics will provide its biomanufacturing partners with an even more robust and premier-quality global supply chain network.

WuXi Biologics views Environmental, Social, and Governance (ESG) responsibilities as an integral component of its ethos and business strategy and aims to become a global ESG leader in biologics manufacturing. We use next-generation cleaner biomanufacturing technologies and cleaner energy to enable global clients. We have also established an ESG committee led by the CEO to increase efficiency while advancing commitment to sustainability. For more information about WuXi Biologics, please visit: www.wuxibiologics.com.

CompanyWuXi Biologics Germany GmbH
Address

CHEMPARK Leverkusen
Building D 201, Gate 133
51368 Leverkusen Germany

E-mail
Internethttps://www.wuxibiologics.com/


As at: 08/2022

x CURRENTA CURRENTA zum Home-Bildschirm hinzufügen:
drücken und dann Zum Home-Bildschirm.